Autoantigen-specific regulatory T cells induced in patients with type 1 diabetes mellitus by insulin B-chain immunotherapy
- 19 November 2009
- journal article
- research article
- Published by Elsevier BV in Journal of Autoimmunity
- Vol. 34 (4), 408-415
- https://doi.org/10.1016/j.jaut.2009.10.005
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Concurrent detection of secreted products from human lymphocytes by microengraving: Cytokines and antigen-reactive antibodiesClinical Immunology, 2008
- GAD Treatment and Insulin Secretion in Recent-Onset Type 1 DiabetesThe New England Journal of Medicine, 2008
- The Foxp3+ regulatory T cell: a jack of all trades, master of regulationNature Immunology, 2008
- Dendritic cells are specialized accessory cells along with TGF-β for the differentiation of Foxp3+ CD4+ regulatory T cells from peripheral Foxp3− precursorsBlood, 2007
- A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-β– and retinoic acid–dependent mechanismThe Journal of Experimental Medicine, 2007
- Reconstitution of paired T cell receptor α- and β-chains from microdissected single cells of human inflammatory tissuesProceedings of the National Academy of Sciences of the United States of America, 2006
- Preservation of C-peptide secretion in subjects at high risk of developing type 1 diabetes mellitus - a new surrogate measure of non-progression?Pediatric Diabetes, 2004
- Intranasally administered insulin intended for prevention of type 1 diabetes—a safety study in healthy adultsDiabetes/Metabolism Research and Reviews, 2003
- Effect of Bacillus Calmette-Guerin vaccination on new-onset type 1 diabetes. A randomized clinical study.Diabetes Care, 1999
- T-cell responses to autoantigens in IDDM. The search for the Holy GrailDiabetes, 1996